Neoadjuvant Therapy of Sintilimab Combined With Chemotherapy for Resectable Squamous Cell NSCLC（neoSCORE Ⅱ）
Clinical trial NCT05429463 · RECRUITING
Trial details
- NCT number
- NCT05429463
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-11
- Primary completion
- 2025-11-11
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.